CI Financial Corp.

DB:CF7 Stock Report

Market Cap: €2.9b

CI Financial Valuation

Is CF7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CF7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CF7 (€20.6) is trading above our estimate of fair value (€9.01)

Significantly Below Fair Value: CF7 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CF7?

Key metric: As CF7 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CF7. This is calculated by dividing CF7's market cap by their current revenue.
What is CF7's PS Ratio?
PS Ratio1.2x
SalesCA$3.59b
Market CapCA$4.39b

Price to Sales Ratio vs Peers

How does CF7's PS Ratio compare to its peers?

The above table shows the PS ratio for CF7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
DWS DWS Group GmbH KGaA
2x-4.3%€8.0b
MLP MLP
0.6x2.3%€671.1m
MUX Mutares SE KGaA
0.1x10.8%€520.9m
AR40 AURELIUS Equity Opportunities SE KGaA
0.1xn/a€346.9m
CF7 CI Financial
1.2x-0.2%€4.4b

Price-To-Sales vs Peers: CF7 is expensive based on its Price-To-Sales Ratio (1.2x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does CF7's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 CompaniesPrice / SalesEstimated GrowthMarket Cap
MLP MLP
0.6x2.3%US$699.71m
MUX Mutares SE KGaA
0.1x10.8%US$543.15m
AR4 AURELIUS Equity Opportunities SE KGaA
0.2x0.01%US$500.05m
AR40 AURELIUS Equity Opportunities SE KGaA
0.1xn/aUS$361.67m
CF7 1.2xIndustry Avg. 2.6xNo. of Companies22PS048121620+
22 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CF7 is good value based on its Price-To-Sales Ratio (1.2x) compared to the German Capital Markets industry average (2.6x).

Price to Sales Ratio vs Fair Ratio

What is CF7's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CF7 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ratio3.3x

Price-To-Sales vs Fair Ratio: CF7 is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (3.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CF7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€20.60
€21.66
+5.1%
0.6%€21.71€21.37n/a6
Dec ’25€20.80
€21.66
+4.1%
0.6%€21.71€21.37n/a6
Nov ’25€15.00
€15.04
+0.3%
14.2%€17.85€10.58n/a8
Oct ’25€12.00
€12.80
+6.7%
10.9%€14.63€10.64n/a8
Sep ’25€11.30
€12.80
+13.3%
10.9%€14.63€10.64n/a8
Aug ’25€11.00
€12.75
+15.9%
9.7%€14.01€10.67n/a9
Jul ’25€9.60
€12.88
+34.2%
10.2%€14.24€10.85n/a9
Jun ’25€9.40
€12.88
+37.1%
10.2%€14.24€10.85n/a9
May ’25€11.00
€13.50
+22.7%
10.2%€15.65€10.89n/a9
Apr ’25€11.60
€13.15
+13.4%
10.3%€15.69€10.92n/a9
Mar ’25€11.40
€13.15
+15.4%
10.3%€15.69€10.92n/a9
Feb ’25€11.20
€12.42
+10.9%
8.2%€14.43€10.99n/a7
Jan ’25€10.10
€11.83
+17.1%
11.0%€14.25€10.18n/a7
Dec ’24€9.35
€11.74
+25.6%
9.6%€13.58€10.19€20.807
Nov ’24€8.40
€11.83
+40.8%
9.6%€13.63€10.22€15.007
Oct ’24€10.80
€13.43
+24.4%
9.9%€15.32€11.14€12.007
Sep ’24€11.70
€13.08
+11.8%
9.3%€14.95€10.87€11.308
Aug ’24€11.30
€13.40
+18.6%
11.6%€16.44€10.96€11.009
Jul ’24€10.20
€12.80
+25.5%
15.9%€15.82€9.29€9.609
Jun ’24€8.90
€12.80
+43.8%
15.9%€15.82€9.29€9.409
May ’24€8.65
€12.62
+45.9%
9.8%€14.95€10.63€11.009
Apr ’24€8.30
€13.35
+60.8%
10.8%€16.32€11.11€11.609
Mar ’24€10.20
€13.35
+30.9%
10.8%€16.32€11.11€11.409
Feb ’24€10.80
€12.98
+20.2%
11.0%€15.76€10.96€11.209
Jan ’24€9.35
€13.18
+41.0%
11.8%€16.02€11.65€10.109
Dec ’23€10.00
€13.18
+31.8%
11.8%€16.02€11.65€9.359

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 05:14
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CI Financial Corp. is covered by 19 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John AikenBarclays
John ReucasselBMO Capital Markets Equity Research
Samira AminiBofA Global Research